Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 1Hepatitis C, Chronic 1Hepatitis C 1Hematologic Neoplasms 1

Interventions

Ribavirin 4ledipasvir, sofosbuvir drug combination 2Chromatography, High Pressure Liquid 2tremelimumab 1telaprevir 1sofosbuvir-velpatasvir drug combination 1pembrolizumab 1peginterferon alfa-2a 1ledipasvir 1grazoprevir 1elbasvir-grazoprevir drug combination 1elbasvir 1Sofosbuvir 1Rapid Diagnostic Tests 1Patient Navigation 1Introns 1Infliximab 1Immunoenzyme Techniques 1Hypothermia, Induced 1Enzyme-Linked Immunosorbent Assay 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hepatitis C × ledipasvir × Clear all
NCT03903185 2023-08-22

Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy

Ain Shams University

Phase 1/2 Completed
24 enrolled
Other hematologic neoplasm

Hepatitis C, Leukemia, Hematologic Neoplasms, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡